Global Centesis Catheters Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Centesis Catheters Market Overview

The Centesis Catheters Market was valued at USD 557.08 million in 2025 and is projected to reach USD 928.91 million by 2033, growing at a CAGR of 6.60% from 2026 to 2033. The market is witnessing steady growth driven by the increasing prevalence of fluid accumulation disorders such as ascites and pleural effusion, rising incidence of chronic liver disease and cancer-related complications, and growing demand for minimally invasive diagnostic and therapeutic procedures.

The expanding geriatric population, coupled with the rising burden of hospital-acquired conditions requiring fluid drainage interventions, is further supporting market adoption. In addition, advancements in catheter design, improved imaging-guided centesis procedures, and growing preference for outpatient and ambulatory care settings are accelerating the uptake of centesis catheters across hospitals, specialty clinics, and diagnostic centers globally.

Key Market Trends & Insights

• North America dominated the Centesis Catheters Market with the largest revenue share of 37.9% in 2025, supported by advanced hospital infrastructure, high procedure volumes, and strong adoption of image-guided minimally invasive drainage procedure.
• The Paracentesis Catheters segment led the market with a 43.82% share in 2025, driven by the rising prevalence of ascites associated with liver cirrhosis, cancer, and chronic kidney disease.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 8.4% from 2026 to 2033, fueled by rising prevalence of chronic diseases, improving diagnostic capabilities, and expanding access to interventional procedures in emerging economies.
• Thoracentesis Catheters are the fastest-growing product type, projected to register a CAGR of 8.3%, reflecting the surge in incidence of pleural effusion associated with cancer, pulmonary infections, heart failure, and tuberculosis.
• The Ultrasound-Guided Centesis segment dominated the procedure type category with a 46.17% revenue share in 2025, led by its high procedural accuracy, reduced complication rates, and growing adoption in bedside interventions.
• Liver Disorders accounted for 39.74% of the market, preferred by the high prevalence of liver cirrhosis and recurrent ascites requiring therapeutic paracentesis.
• The Oncology segment is the fastest-growing application category, with a CAGR of 8.5%, driven by rising incidence of cancer-related pleural effusion and malignant ascites.

Market Size & Forecast

• Global Market Value (2025): USD 557.08 Million
• Expected Market Value (2033): USD 928.91 Million
• Forecast CAGR (2026–2033): 6.60%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia Pacific

Report Scope and Centesis Catheters Market Segmentation

Centesis Catheters Market Trends

Trend: Increasing Adoption of Image-Guided Minimally Invasive Drainage Procedures

Hospitals and specialty care centers are increasingly adopting image-guided centesis catheters to improve procedural accuracy, reduce patient complications, and enhance overall clinical outcomes without the risks associated with more invasive surgical interventions. The integration of portable ultrasound systems enables real-time visualization of fluid accumulation and surrounding anatomical structures during drainage procedures. Oncology clinics and emergency departments are similarly utilizing centesis catheters for rapid therapeutic relief through standardized, minimally invasive treatment protocols, while advancements in catheter materials and disposable drainage kits are improving procedural safety and patient comfort across both inpatient and outpatient healthcare environments.

For instance, in March 2025, Becton, Dickinson and Company expanded its ultrasound-guided drainage catheter portfolio designed to support safer bedside fluid management procedures in critical care and oncology settings globally.

Centesis Catheters Market Dynamics

Key Market Driver: Rising Prevalence of Chronic Diseases Requiring Fluid Drainage Procedures

The increasing prevalence of chronic liver disease, cancer, heart failure, and pulmonary disorders has created substantial demand for centesis catheters that enable safe and minimally invasive therapeutic fluid drainage across diverse healthcare environments. Hospitals, ambulatory care centers, and specialty clinics are increasingly deploying advanced catheter systems as a core component of patient management strategies, reducing hospitalization burden, improving procedural efficiency, and enhancing patient comfort during recurrent drainage interventions. Growing awareness regarding early diagnosis and minimally invasive treatment approaches is further supporting procedural adoption worldwide, particularly in aging populations with rising incidence of chronic and oncology-related complications.

For instance, in January 2025, Teleflex Incorporated introduced an enhanced drainage catheter system focused on improving efficiency and patient safety during thoracentesis and paracentesis procedures performed in acute care facilities.

Key Restraint/Challenge: Risk of Procedure-Related Complications and Skilled Workforce Limitations

A significant restraint in the Centesis Catheters Market is the risk of procedural complications associated with improper catheter placement, infection, bleeding, and organ injury during fluid drainage interventions performed across complex clinical environments. Modern centesis procedures require skilled healthcare professionals, imaging guidance systems, and strict infection control protocols, creating operational challenges for smaller healthcare facilities and resource-limited institutions. The total burden of procedural training, equipment maintenance, and patient monitoring further increases operational complexity, limiting widespread adoption in underdeveloped healthcare systems. Shortages of trained interventional radiologists and emergency care specialists continue to restrict access to advanced image-guided drainage procedures across several emerging markets globally.

For instance, in September 2024, a clinical safety review published by the Society of Interventional Radiology highlighted ongoing concerns regarding complication management and workforce shortages affecting minimally invasive drainage procedure accessibility worldwide.

Key Market Opportunity: Expansion of Outpatient and Home-Based Fluid Drainage Solutions

The expansion of outpatient care and home-based fluid drainage management presents a significant market opportunity for centesis catheter manufacturers. Advanced catheter systems can support long-term therapeutic drainage, improve patient convenience, and reduce healthcare costs associated with repeated hospital admissions and prolonged inpatient treatment requirements. The development of portable drainage kits, antimicrobial catheter coatings, and patient-friendly disposable systems is further improving accessibility across ambulatory and home healthcare settings. Increasing demand for palliative care services and decentralized healthcare delivery models is also creating strong growth opportunities across cost-sensitive healthcare markets in Asia-Pacific, Latin America, and the Middle East.

For instance, in February 2025, Merit Medical Systems announced the expansion of its outpatient drainage solutions portfolio targeting ambulatory care and home-based management for recurrent pleural and abdominal fluid conditions.

Centesis Catheters Market Scope

The centesis catheters market is segmented on the basis of product type, procedure type, application, end user.

• By Product Type

On the basis of product type, the Centesis Catheters Market is segmented into paracentesis catheters, thoracentesis catheters, amniocentesis catheters, and pericardiocentesis catheters. The Paracentesis Catheters segment dominated the market with a 43.82% share in 2025, owing to the rising prevalence of ascites associated with liver cirrhosis, cancer, and chronic kidney disease. These catheters are widely used in hospitals and specialty clinics for both diagnostic and therapeutic fluid drainage procedures. Their minimally invasive nature, reduced recovery time, and lower complication risk are supporting broader clinical adoption. Increasing hospitalization rates linked to gastrointestinal and hepatic disorders are further driving procedural volumes globally. Advancements in catheter flexibility, drainage efficiency, and ultrasound-guided insertion techniques are improving patient outcomes and procedural accuracy. The segment also benefits from growing awareness regarding early fluid management and expanding access to interventional care in developing healthcare systems.

The Thoracentesis Catheters segment is projected to register the fastest growth at a CAGR of 8.3% from 2026 to 2033, driven by the increasing incidence of pleural effusion associated with cancer, pulmonary infections, heart failure, and tuberculosis. These catheters are increasingly preferred for safe and efficient pleural fluid drainage in emergency and critical care settings. Growing use of image-guided thoracentesis procedures is significantly improving precision and reducing procedural complications. Technological advancements in disposable catheter kits and vacuum-assisted drainage systems are further accelerating adoption. Rising demand for minimally invasive respiratory interventions and increasing geriatric patient populations are also contributing to market expansion. Expanding pulmonary care infrastructure across emerging economies is expected to create substantial growth opportunities during the forecast period.

• By Procedure Type

On the basis of procedure type, the Centesis Catheters Market is segmented into ultrasound-guided centesis, CT-guided centesis, fluoroscopy-guided centesis, and blind/manual centesis procedures. The Ultrasound-Guided Centesis segment led the market with a 46.17% share in 2025, driven by its high procedural accuracy, reduced complication rates, and growing adoption in bedside interventions. Ultrasound guidance enables real-time visualization of fluid accumulation and surrounding anatomical structures, improving procedural safety and efficiency. Hospitals and ambulatory care centers are increasingly adopting portable ultrasound systems for rapid and minimally invasive drainage procedures. The technique also reduces the need for repeated attempts, lowering patient discomfort and hospital stay duration. Rising availability of trained interventional radiologists and emergency physicians is further supporting widespread utilization. Continuous advancements in compact imaging systems and AI-assisted imaging workflows are strengthening the segment’s market dominance globally.

The CT-Guided Centesis segment is expected to witness the fastest growth at a CAGR of 8.1% from 2026 to 2033, owing to the increasing need for high-precision interventions in complex anatomical cases. CT-guided procedures are particularly beneficial for deep-seated or difficult-to-access fluid collections where ultrasound visibility is limited. These systems provide enhanced imaging resolution and detailed anatomical mapping, improving clinical outcomes in oncology and trauma-related interventions. Growing use in tertiary care hospitals and advanced diagnostic centers is accelerating segment growth. Rising demand for precision-guided minimally invasive procedures and expanding radiology infrastructure are also contributing significantly to adoption. Increasing integration of AI-enabled imaging analysis and navigation technologies is expected to further enhance procedural efficiency and market penetration.

• By Application

On the basis of application, the Centesis Catheters Market is segmented into oncology, liver disorders, cardiovascular disorders, renal disorders, and pulmonary diseases. The Liver Disorders segment dominated the market with a 39.74% share in 2025, primarily due to the high prevalence of liver cirrhosis and recurrent ascites requiring therapeutic paracentesis. Increasing alcohol-related liver disease cases and viral hepatitis burden are significantly contributing to procedure demand worldwide. Hospitals frequently perform fluid drainage procedures to relieve abdominal pressure and improve patient comfort in chronic liver disease management. Growing awareness regarding early diagnosis and treatment of hepatic complications is also supporting market growth. Technological improvements in catheter materials and infection prevention measures are enhancing procedural outcomes. In addition, increasing healthcare expenditure and expanding hepatology care services in developing economies continue to strengthen segment expansion.

The Oncology segment is projected to register the fastest growth at a CAGR of 8.5% from 2026 to 2033, driven by the rising incidence of cancer-related pleural effusion and malignant ascites. Cancer patients increasingly require repeated fluid drainage procedures for symptom management and palliative care support. Growing adoption of minimally invasive interventional oncology procedures is further accelerating the use of advanced centesis catheters. Increasing global cancer burden, particularly in lung, ovarian, and gastrointestinal cancers, is substantially driving procedural volumes. Improvements in catheter durability and patient-friendly drainage systems are supporting long-term therapeutic use. Expanding oncology treatment infrastructure and rising investments in supportive cancer care are expected to create strong market opportunities throughout the forecast period.

• By End User

On the basis of end user, the Centesis Catheters Market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and diagnostic imaging centers. The Hospitals segment accounted for the largest market share of 52.31% in 2025, supported by high patient admissions, availability of advanced imaging systems, and access to skilled interventional specialists. Hospitals perform a large volume of centesis procedures across emergency care, oncology, pulmonology, and hepatology departments. The presence of integrated diagnostic and surgical infrastructure enables efficient management of complex fluid drainage procedures. Increasing investments in minimally invasive treatment technologies and patient safety protocols are further driving adoption within hospital settings. Hospitals also benefit from reimbursement support and strong procedural capabilities for high-risk patients. Growing demand for inpatient and critical care interventions continues to reinforce this segment’s dominance globally.

The Ambulatory Surgical Centers segment is anticipated to witness the fastest growth at a CAGR of 8.0% from 2026 to 2033, driven by the rising preference for outpatient minimally invasive procedures. These facilities offer cost-effective treatment options, shorter procedure times, and reduced hospital stay durations, making them increasingly attractive for routine centesis interventions. Improvements in portable imaging systems and disposable catheter technologies are supporting procedural expansion in ambulatory settings. Rising healthcare cost containment efforts and growing patient preference for same-day procedures are accelerating adoption globally. Increasing establishment of specialized outpatient interventional centers in emerging economies is also contributing to growth. The segment is further benefiting from expanding insurance coverage and growing focus on decentralized healthcare delivery models.

Centesis Catheters Market Regional Analysis

North America dominated the Centesis Catheters Market with the largest revenue share of 37.9% in 2025, supported by advanced hospital infrastructure, high procedure volumes, and strong adoption of image-guided minimally invasive drainage procedure. The region also benefits from strong adoption of ultrasound-guided centesis procedures, favorable reimbursement frameworks, and increasing use of catheters across oncology, hepatology, pulmonology, and emergency care applications. Growing focus on early disease management and outpatient fluid drainage solutions continues to strengthen North America’s leadership position in the global market.

U.S. Centesis Catheters Market Insight

The U.S. centesis catheters market is witnessing strong growth due to rising prevalence of chronic liver disease, cancer-related effusions, and increasing demand for minimally invasive drainage procedures. The country’s advanced healthcare infrastructure, along with growing adoption of ultrasound-guided and image-assisted catheter systems, is driving demand across hospitals, ambulatory centers, and specialty clinics. In addition, increasing emphasis on improving patient outcomes and reducing hospitalization duration is accelerating centesis catheter adoption across interventional radiology and emergency care departments.

Europe Centesis Catheters Market Insight

The Europe centesis catheters market remains a major contributor to global revenue, driven by strong healthcare infrastructure, technological innovation, and high demand for minimally invasive treatment solutions. The widespread use of image-guided catheter procedures in oncology, hepatology, and pulmonary care programs is supporting market expansion across the region. Increasing investments in advanced drainage technologies, coupled with favorable healthcare policies and a highly skilled medical workforce, continue to enhance the adoption of centesis catheters throughout Europe.

U.K. Centesis Catheters Market Insight

The U.K. centesis catheters market is experiencing steady growth, supported by rising adoption of minimally invasive drainage procedures in hospitals, specialty clinics, and emergency care settings. Increasing investments in advanced interventional radiology infrastructure and growing demand for cost-effective, patient-friendly treatment solutions are contributing to market growth. Furthermore, integration of portable ultrasound technologies and improved catheter design innovations is enhancing procedural efficiency and patient safety, positioning the U.K. as a key innovation hub in the centesis catheters industry.

Germany Centesis Catheters Market Insight

The Germany centesis catheters market is expanding steadily due to the country’s advanced healthcare system, strong medical technology sector, and increasing adoption of image-guided interventional procedures. Healthcare providers, diagnostic centers, and specialty hospitals are increasingly utilizing centesis catheters for fluid drainage, therapeutic interventions, and critical care management activities. Continuous advancements in catheter materials, imaging integration, and minimally invasive technologies, along with strong government focus on healthcare quality and innovation, are further driving market growth in Germany.

Asia-Pacific Centesis Catheters Market Insight

The Asia-Pacific centesis catheters market is expected to witness rapid growth, driven by increasing prevalence of chronic diseases, expanding healthcare infrastructure, and rising investments in interventional care services across countries such as China, India, and Japan. Growing awareness regarding minimally invasive treatment options, rising adoption of advanced imaging technologies, and increasing demand for affordable and efficient drainage procedures are supporting regional market expansion. In addition, the growing presence of specialty hospitals and improving access to healthcare services is accelerating centesis catheter adoption across clinical and outpatient settings.

Japan Centesis Catheters Market Insight

The Japan centesis catheters market is witnessing consistent growth due to rising investments in advanced medical technologies, aging population trends, and increasing focus on minimally invasive healthcare solutions. Hospitals, oncology centers, and research institutions are increasingly adopting image-guided centesis procedures for therapeutic drainage, critical care, and chronic disease management purposes. Moreover, increasing integration of precision imaging systems and the country’s focus on efficient and high-quality healthcare delivery are further contributing to market growth.

China Centesis Catheters Market Insight

The China centesis catheters market is growing rapidly, driven by increasing chronic disease burden, expanding healthcare infrastructure, and rising government focus on improving interventional and emergency care services. Growing adoption of ultrasound-guided and minimally invasive drainage procedures across hospitals, oncology centers, and specialty clinics is significantly boosting market demand. In addition, rising investments in healthcare modernization, increasing awareness regarding early disease management, and rapid technological advancements are positioning China as one of the fastest-growing markets for centesis catheters globally.

Centesis Catheters Market Share

The centesis catheters industry is primarily led by well-established companies, including:

• BD (U.S.)
• Teleflex Incorporated (U.S.)
• Merit Medical Systems, Inc. (U.S.)
• Cook Medical (U.S.)
• Argon Medical Devices, Inc. (U.S.)
• Cardinal Health (U.S.)
• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• Braun SE (Germany)
• AngioDynamics, Inc. (U.S.)
• ICU Medical, Inc. (U.S.)
• Rocket Medical plc (U.K.)
• Smiths Medical (U.K.)
• Vygon SAS (France)
• Galt Medical Corp. (U.S.)
• Pfm medical ag (Germany)
• Romsons Group Private Limited (India)
• Well Lead Medical Co., Ltd. (China)
• Redax S.p.A. (Italy)
• Bioteque Corporation (Taiwan)

Latest Developments in Centesis Catheters Market

• In June 2025, Teleflex Incorporated announced positive multinational study results for its Arrow™ chlorhexidine-impregnated central venous catheters, demonstrating a 70.5% reduction in bloodstream infection rates among ICU patients compared to standard catheters. The study involved more than 6,670 patients across eight hospitals and highlighted the growing importance of infection-prevention technologies in catheter-based interventional procedures and fluid management applications
• In April 2025, Merit Medical Systems announced the commercial launch of the Ventrax™ Delivery System, an all-in-one retrograde aortic access catheter platform designed to improve catheter placement and procedural efficiency during complex cardiac interventions. The launch strengthened the company’s interventional catheter portfolio and reflected increasing innovation in minimally invasive catheter-based technologies used across radiology and therapeutic drainage procedures
• In January 2025, Argon Medical Devices acquired the SeQure and DraKon microcatheter product lines from Interventional Systems, expanding its interventional oncology and minimally invasive catheter portfolio. The acquisition enhanced the company’s capabilities in precision therapeutic delivery and reinforced broader industry trends toward advanced catheter innovation and image-guided intervention technologies
• In November 2024, Rocket Medical initiated a recall of selected thoracentesis catheter products due to adhesive-related manufacturing concerns affecting device performance. The development highlighted the increasing industry focus on catheter safety, manufacturing quality assurance, and regulatory compliance across minimally invasive drainage and centesis procedure markets
• In September 2024, Becton, Dickinson and Company (BD) completed the acquisition of Edwards Lifesciences’ Critical Care product group, including the Swan-Ganz pulmonary artery catheter portfolio. The acquisition significantly strengthened BD’s vascular access and connected care capabilities while expanding its presence in advanced catheter monitoring and interventional care technologies globally

SKU-55920